Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Ip Group Plc
Life Sciences update event
Published Jun 8 2023
3 min read

Life Sciences update event

FOR RELEASE ON

08 June 2023

IP Group - Life Sciences investor update

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces that it will hold a life sciences investor update on Thursday June 15 2023 featuring Dr Gordon Sanghera, CEO of Oxford Nanopore Technologies plc, and Professor Sir Peter Donnelly, CEO of portfolio company Genomics.

 

The event will be hosted by CEO Greg Smith and Dr Sam Williams, Managing Partner of Life Sciences at IP Group, and, as announced on 20 April 2023, will be followed by the Group's Annual General Meeting at 11am. Further details of the event and how to register can be found here: bit.ly/3oUjNqb.

 

The update will also be available remotely through the Investor Meet Company platform. Questions can be submitted in advance of the event via the Investor Meet Company Platform up to 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: https://www.investormeetcompany.com/ip-group-plc/register-investor. Investors who already follow IP Group plc on the Investor Meet Company platform will automatically be invited.

 

No material new information will be released by the Company during the presentation.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Vic Wallin

Alex Donaldson

+44 (0) 7973 823119

+44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. Athe most active UK based, early stage science investorwe develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutionsOur specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS